Full Text View
Tabular View
No Study Results Posted
Related Studies
Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors
This study has been terminated.
Study NCT00112684   Information provided by National Cancer Institute (NCI)

First Received on June 2, 2005.   Last Updated on April 10, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
alvocidib
pharmacological study
laboratory biomarker analysis
Additional drug interventions recognized in this trial
Flavopiridol
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services